Oral Oncology

Article	Citations
Incorporation of PD-1 blockade into induction chemotherapy improved tumor response in patients with locoregionally advanced nasopharyngeal carcinoma in a retrospective patient cohort	226
The coagulome of Head and Neck Squamous Cell Carcinoma	83
Comment on, “Development of a prediction model for tube feeding dependence in HPV-associated oropharyngeal cancer patients undergoing chemoradiotherapy”	61
Pathologic responses and clinical outcomes with neoadjuvant doublet chemotherapy for newly diagnosed, surgically-resectable p16-positive oropharyngeal cancer	56
Omitting elective neck dissection in cT1/2N0 oral squamous cell carcinoma with sentinel lymph node metastasis: A prospective study	54
Does identification of determinants that delay adjuvant treatment and discussing the benefits of adjuvant treatment with patients create an impact?	44
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review	39
Alcohol attributed Oral Cancer and Oral microbiome: Emerging yet neglected research domain	37
Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma	36
Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients	36
Prospective comparison of acute severe toxicities between smokers and non-smokers during radiotherapy for head and neck cancers	35
The spiral ladder technique of facial nerve trunk identification during parotidectomy: A convenient roadmap for the beginners	34
The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site	33
MicroRNA expression is associated with human papillomavirus status and prognosis in mucosal head and neck squamous cell carcinomas	31
Risk, prevention, screening and management of carotid artery stenosis in head & neck cancer patients—An evidence based review	29
Letter to the editor, “Letter to the editor, “Short-term versus long-term metronomic adjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: A propensity score-matched real-world study.”	29
The efficacy of adjuvant chemotherapy in patients with different midpoint-radiotherapy Epstein-Barr virus DNA plasma loads	29
The circadian clock gene, BMAL1, promotes radiosensitization in nasopharyngeal carcinoma by inhibiting the epithelial-to-mesenchymal transition via the TGF-β1/Smads/Snail1 axis	28
Division versus de-epithelialization of fibula osteocutaneous flap for composite oromandibular defects: A propensity score-matched analysis	28
Utility of bioselection with neoadjuvant chemotherapy for organ preservation in patients with T4 laryngeal cancer	28
Reflectance confocal microscopy (RCM)-based criteria for progression of lower-lip squamous cell carcinoma: A prospective study	27
Comparison of the 8th edition of TNM staging of oral cancer with the 7th edition and its prognostic significance using clinical depth of invasion and extranodal extension	27
Systematic review and meta-analysis of randomized controlled trials comparing elective neck dissection versus sentinel lymph node biopsy in early-stage clinically node-negative oral and/or oropharynge	27
Enhanced oral versus flank lymph node T cell response parallels anti-PD1 efficacy in head and neck cancer	26
Lymph node level ratio as a predictor of survival in oral cavity squamous cell carcinoma	26

Diagnostic value of indocyanine green for sentinel lymph node mapping and lymph node metastasis in oral/oropharyngeal carcinoma	26
A rare case of squamous cell carcinoma of the gingiva: A diagnostic challenge	25
Author’s reply to comment on “awareness regarding oral cancer amongst the dental, medical, and nursing students: Is something lacking?”	25
Modifiable risk factors for oral cavity cancer in non-smokers: A systematic review and meta-analysis	25
Prognostic effect of surgical treatment in elderly oral squamous cell carcinoma patients: A retrospective study	25
Sentinel lymph node biopsy in recurrent or secondary oral squamous cell carcinoma after previous neck dissection	24
Letter to the Editor: “Immune infiltration at the primary tumor is associated with clinical outcome of patients with extranodal extension of lymph node metastasis in oral Cancer”	24
Histone deacetylase inhibitors regulate the oral cancer via PI3K/AKT signaling pathway	24
Lower cranial nerve palsy after hypofractionated radiotherapy in a laryngeal cancer patient: A letter to the editor	24
Salvage total glossectomy and total glosso-laryngectomy: Are they worth it? A GETTEC French multicenter study	23
Letter to editor on “Proton therapy re-irradiation outcomes and genomic landscape of patients with recurrent head and neck cancer”	23
Metachronous second primary neoplasia in oropharyngeal cancer patients: Impact of tumor HPV status. A GETTEC multicentric study	23
Survival and functional outcomes after total glossectomy with total laryngectomy: Case series from a high-volume tertiary institution	23
Need for clarification on pathological tumor size for lip and oral cavity cancers with size ≤ 2 cm and depth of Invasion > 10 mm: A letter to the editor	23
Is the current oropharyngeal cancer T classification adequate in the era of HPV and transoral robotic surgery?	22
Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort	22
Clinical outcomes of oropharyngeal squamous cell carcinoma stratified by human papillomavirus subtype: A systematic review and meta-analysis	22
Simultaneously targeting ErbB family kinases and PI3K in HPV-positive head and neck squamous cell carcinoma	21
Early response dynamics predict treatment failure in patients with recurrent and/or metastatic head and neck squamous cell carcinoma treated with cetuximab and nivolumab	21
Refining TNM-8 M1 categories with anatomic subgroups for previously untreated de novo metastatic nasopharyngeal carcinoma	21
Prognostic value of CD103+ tumor-infiltrating lymphocytes and programmed death ligand-1 (PD-L1) combined positive score in recurrent laryngeal squamous cell carcinoma	21
Synergistic efficacy of combined EGFR and HDAC inhibitors overcomes tolerance to EGFR monotherapy in salivary mucoepidermoid carcinoma	20
Role of surgical margins in transoral robotic surgery: A question yet to be answered	20
Dissemination patterns and chronology of distant metastasis affect survival of patients with head and neck squamous cell carcinoma	19
Assessment and treatment strategies for occult contralateral lymph node metastasis in hypopharyngeal squamous cell carcinoma patients with ipsilateral node-positive necks	19
The impact of early oral feeding following head and neck free flap reconstruction on complications and length of stay	19
Osteoradionecrosis after postoperative radiotherapy for oral cavity cancer: A retrospective cohort study	18
Complete response with pembrolizumab in recurrent squamous cell carcinoma of the oral tongue: A case report	18
Characterization of oral microbiota in HPV and non-HPV head and neck squamous cell carcinoma and its association with patient outcomes	18
Long term survival in patients with human papillomavirus-positive oropharyngeal cancer and equivocal response on 12-week PET-CT is not compromised by the omission of neck dissection	18
Noninvasive genomic profiling of somatic mutations in oral cavity cancers	18
Fever range whole body hyperthermia for re-irradiation of head and neck squamous cell carcinomas: Final results of a prospective study	18
Oral cancer histopathology images and artificial intelligence: A pathologist's perspective	18
The prognostic value of radiologic extranodal extension in nasopharyngeal carcinoma: Systematic review and meta-analysis	18
Oncological outcomes of compartmental surgery and wide local excision in oral tongue and floor of the mouth cancer	18
Machine learning driven index of tumor multinucleation correlates with survival and suppressed anti-tumor immunity in head and neck squamous cell carcinoma patients	18
Tongue reconstruction by submental flap	18
Evaluation of head and neck soft tissue sarcoma 8th edition pathologic staging system and proposal of a novel stage grouping system	18
Diagnostic efficacy of PET-CT, CT, and MRI in preoperative assessment of mandibular invasion caused by head and neck cancer: A systematic review and meta-analysis	17
Salivary gland cystadenocarcinoma: Rare neoplasm in buccal mucosa	17
A brief overview of 100 best-cited papers on oral submucous fibrosis in Oral Oncology	17
Field cancerization revisited in purview of quantum entanglement: Delving into the unexplored	17
Pharmacodynamic and therapeutic pilot studies of single-agent ribavirin in patients with human papillomavirus–related malignancies	17
TransOral UltraSonic surgery (TOUSS) for oral cavity, oropharyngeal and supraglottic malignancy: A prospective study of feasibility, safety, margins, functional and survival outcomes	17
Isothiocyanates (AITC & BITC) bioactive molecules: Therapeutic potential for oral cancer	16
Squamous odontogenic tumor like proliferations in dentigerous cyst- a great mimicker	16
Synchronous adenoid cystic carcinoma in the submandibular gland and tongue: A rare case report	16
Cavernous sinus metastasis in head and neck cancer: Focus on oral squamous cell cancer	16
Prevalence of occult level 2b nodal metastases in cN0 squamous cell carcinoma of the oral cavity: A systematic review and meta-analysis	16
Felodipine repurposed for targeting TRPV1 receptor to relieve oral cancer pain	16

Extraskeletal Ewing’s sarcoma of supraglottis: A rare case report	16
Scales to graduate oral mucositis: What are the limitations?	16
Oncologic and functional results between sentinel lymph node biopsy and elective neck dissection in cT1/2N0 maxillary squamous cell carcinoma	15
Development and characterization of patient-derived salivary gland cancer organoid cultures	15
Quality of life in patients with oral squamous cell carcinoma: A critical assessment tool, sadly ignored!	15
WIPI-1 inhibits metastasis and tumour growth via the WIPI-1-TRIM21 axis and MYC regulation in nasopharyngeal carcinoma	15
The effect of treatment package time on locally advanced oral cavity cancer outcomes	15
The challenging diagnosis of low-grade myofibroblastic sarcoma: A case report and literature update	15
Head and neck cancer with synchronous nodules of the lung as a diagnostic and therapeutic challenge – A systematic review	15
Upfront neck dissection to guide single-modality therapy for early stage supraglottic squamous cell carcinoma	15
PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data	15
What's ahead for complete responders following NACT?	15
Exophytic verrucous hyperplasia as a clinical terminology includes verrucous hyperplasia with or without epithelial dysplasia in histology	15
Diagnostic accuracy of intraoperative margin assessment techniques in surgery for head and neck squamous cell carcinoma: A meta-analysis	14
The characteristics and prospects of reflectance confocal microscopy for noninvasive diagnosis of oral potentially malignant disorders	14
Editorial Board/Aims & Scope	14
8 “S” of obturators in Head and Neck Cancer Rehabilitation during COVID-19 pandemic	14
Diagnostic tips for parotid lymphoma	14
A case of metastatic NUT carcinoma of the nasal cavity	14
P-225 A comparison of clinical and pathological TNM staging in a COVID-19 era	14
Oral epithelioid rhabdomyosarcoma: Report of a rare case and literature review of a distinct variant of rhabdomyosarcoma	14
A rare combined motley variety of odontogenic tumors – Hybrid lesion or a new entity?	14
Transoral endoscopic thyroidectomy using a self-retaining retractor as an alternative to carbon dioxide gas insufflation: A comparative analysis of 131 cases	14
COVID-19 pandemic and lock-down protocols: Impact in an indian tertiary cancer center	14
Chondromyxoid fibroma affecting the maxilla in a 1-year-old child: Immunohistochemical analysis and literature review	14
Development and validation of a population-based model for predicting the regional lymph node metastasis in adolescent differentiated thyroid carcinoma	14
The development of a decision aid for patients with operable oropharyngeal carcinoma in the Netherlands – A mixed methods study	13
Comment on “Predictors of prolonged treatment time intervals in oral cavity cancer”	13
Atypical metastases highlight the true potential of ctDNA liquid biopsies for cancer monitoring	13
Patient specific follow-up to monitor the risk of malignant transformation on oral mucosa	13
Revaluation of the treatment of head and neck cancer in Brazil during the COVID-19 pandemic - phase 2	13
Can koilocytes without dysplasia in OPMDs be an early indicator and prognostic factor for oral squamous cell carcinoma?	13
Methodological challenges in identifying histological prognostic markers for squamous cell carcinoma of the lip, mouth, and oropharynx	13
P-54 Response rate after chemoembolization with followed radiation therapy in patients with locally advanced nasopharyngeal carcinoma	13
Malignant melanoma in situ of the palate: Radical treatment or “watch and wait”? An update reporting an adverse outcome	13
Reply to: Comment on “Transoral robotic surgery in oropharyngeal squamous cell carcinoma: A comparative study between da Vinci Single-Port and da Vinci Xi systems”	13
Phantom study of SPECT/CT augmented reality for intraoperative localization of sentinel lymph nodes in head and neck melanoma	13
Primary oral melanoma: ABCDE or AEIOU criteria for clinical diagnosis?	13
Mycobiota profile of oral fungal infections in head and neck cancer patients receiving radiotherapy: A 6-year retrospective MALDI-TOF mass spectrometry study	13
Editorial Board/Aims & Scope	13
Betel-nut chewing does not influence PD-L1 expression rates in recurrent/metastatic head and neck squamous cell carcinoma (HNSCC): A prospective biomarker prevalence study	13
Association of follow-up imaging frequency with temporal incidence and patterns of distant failure following (chemo) radiotherapy for HPV related oropharyngeal cancer	13
Association Between Social Determinants of Health, Distance from Treatment Center, and Treatment Type with Outcomes in Human Papillomavirus Associated Oropharyngeal cancer	12
Clinicopathological factors associated with progression of oral submucous fibrosis: A population-based retrospective study	12
Editorial Board/Aims & Scope	12
Geographical heterogeneity in the American Joint committee on Cancer oral cancer staging and prognostic implications	12
ERα: A biomarker and treatment target for oropharyngeal cancer?	12
CENPM upregulation by E5 oncoprotein of human papillomavirus promotes radiosensitivity in head and neck squamous cell carcinoma	12
Editorial Board/Aims & Scope	12
Quantitative malignant index diagnosis system (qMIDS) for effective diagnosis of oral premalignant lesions	12
A destructive sinonasal organizing hematoma mimicking malignancy	12
Novel tyrosine metabolites in the transcriptomic profiling of smokeless tobacco related oral cancer and their potential implications	12
Hypofractionated chemoradiation (2.75 Gy per fraction) in Head and Neck Cancer: Extreme caution required	12
Ultrasound Scan Pre-Operative Localization of Recurrent Thyroid Cancer – Technique and Early Outcomes	11
Regarding to “Minimaly invasive benign parotid surgery in selected patients: An adaptation example to compensate for COVID19 backlog or new era?”	11
Nasopharyngeal Brush Epstein Barr Viral DNA in the Detection of Locally Recurrent Nasopharyngeal Carcinoma	11
Invasive oral squamous cell carcinoma of maxillary alveolus in a Nicobari tribal woman after 17 years of tobacco cessation – A case report	11
Ramucirumab-related osteonecrosis of the jaw	11
“Haemophilia A” – Presenting with oral squamous cell carcinoma diagnosis and management strategies	11
A N6-methyladenosine-related long noncoding RNAs model for predicting prognosis in oral squamous cell carcinoma: Association with immune cell infiltration and tumor metastasis	11
O5.1 Deciphering knowledge and opinions of HPV and HPV vaccination for facilitation of point-of-care vaccination	11
P-115 The potential of panel-based gene expression analysis in the identification of head and neck cutaneous squamous cell carcinoma with high risk of lymph node metastasis	11
Transoral surgery may be less cost effective than radiotherapy	11
Young age is not a predictor of disease specific survival in oral cancer: A multi-institutional study	11
Clinical features of post-radiation nasopharyngeal necrosis and their outcomes following surgical intervention in nasopharyngeal cancer patients	11
Extra imaging beyond NCCN surveillance guidelines is cost effective for HPV− but not HPV+ oropharyngeal cancer	11
Sentinel lymph node biopsy-does the building evidence tick all the boxes to make it a standard of care as of today?	11
Impact of invasion into cervical esophagus for patients with hypopharyngeal squamous cell carcinoma	11
Oral field cancerization: A critical appraisal	11
Salvage Treatment in Isolated Regional Recurrent Head and Neck Squamous Cell Carcinoma	11
P-24 Circulating tumor DNA as a marker of Minimal Residual Disease in squamous cell carcinoma of the head and neck: an agnostic approach	11
P-67 Dosimetric results and NTCP models comparison between VMAT and IMPT for nasopharyngeal cancer patients	11
Unravelling the long non-coding RNA, CYTOR can serve as a potential therapeutic target in oral cancer	11
The Role of microRNAs as a predictive biomarker and therapeutic molecule in the treatment of Oral Potentially Malignant Disorder (OPMD)	11
P28 Head and neck cancer cells differentiate resembling their tissue of origin	11
Hypopharyngeal dedifferentiated liposarcoma: What we have learned so far	11
O4.2 Early detection of recurrent HPV-positive HNSCC by ctDNA analysis	11
Circulatory microRNAs inhibition and its signaling pathways in the treatment of oral squamous cell carcinoma (OSCC)	11
Clinical and treatment course of lung carcinoma from adult-onset recurrent respiratory papillomatosis with lung involvement: A case report	11
Glandular metaplasia in oral squamous cell carcinoma: Prognostic indicators? Deriving inference from urothelial and breast carcinoma	11

P-242 Laryngeal metastasis from lung cancer: A case report	11
P-238 Nasosinusal Lymphoepithelial carcinoma	10
P-109 Androgen deprivation therapy for salivary gland tumours: experience of a single institution	10
P-25 Socioeconomic inequality in survival after oropharynx cancer according to HPV-status: the impact of stage, smoking and comorbidity – a nationwide study from DAHANCA	10
P-164 Transoral laser resection of early supraglottic tumours, comparative quality of life study and cost benefit versus horizontal supraglottic laryngectomy	10
P07 The tumor immune microenvironment and its association with progression free survival in patients with oropharyngeal squamous cell carcinoma	10
Editorial Board/Aims & Scope	10
A rare case of Kimura disease with lumps on the cheek and behind the ear	10
Psychosocial Factors in an Oral Cancer Survivor Leading to Delay in Seeking Help	10
P-41 Pattern of failure in oropharyngeal cancer patients treated with IMRT: comparison of two different CTV expansion modalities	10
P-49 Could organ sparing radiotherapy for larynx cancer have prevented World War I?	10
The positive yield of multidisciplinary team decisions in a high volume head and neck center after those made in its preferred partner: An example of enhanced quality of care	10
P-50 Oropharyngeal Cancer; Survival of the Elderly	10
Is locally advanced head and neck cancer ‘increasing’ in the Netherlands? The paradox of absolute numbers, standardized incidence rates and proportional share	10
P-247 Neck Mass in a Young Adult – An Atypical Case of Lymphoma solved with biopsy	10
A case of liposarcoma with osteolysis of the maxilla as the first symptom and review of the literature	10
Editorial Board/Aims & Scope	10
P-217 Evaluation of the percutaneous endoscopic gastrostomy in situ rates following completion of radical treatment in patients with oropharyngeal squamous cell carcinomas: a single centre experience	10
P19 Detection of HPV16 cell-free DNA in liquid biopsies for early detection of HPV-OPC	10
P-31 Oral Squamous Cell Carcinoma in Patients with 45 Years or Under – 7 Years Experience of an Oral Medicine Centre	10
P-261 Laryngeal Dysplasia: A Systematic Review of Prognostic Factors in the Development of Malignancy	10
P-117 Oncological outcomes of patients with parotid metastasis of skin malignancies	10
P-165 Opportunities for surgical treatment of elderly patients with head and neck tumors	10
P-257 Cervical lymphadenopathy following COVID-19 vaccine: Clinical characteristics and implications for head and neck cancer services	10
P-16 Evaluation of two ratios predicting natural killer cell function in nasopharyngeal and other head and neck cancers patients leading towards better prognosis	10
P-66 Locally advanced cancers of larynx or hypopharynx: Real world management outcomes and prognostic factors in the IMRT era at South Yorkshire cancer network, UK	9
P-130 The effect of fibrin sealant glue in reducing post-operative collections following parotidectomy	9
P-144 Tongue Carcinoma Case Treated with a Pull Through Procedure Approach with Better Esthetic Outcomes	9
P-158 Outcomes of submental flap reconstruction fororal defects in surgical treatment of oral cancer	9
P-72 Hypofractionated, Dose redistributed RAdiotherapy for head and neck squamous cell carcinoma (HYDRA)	9
P-140 Clinical outcomes following pharyngolaryngectomy reconstruction: a 20-year single centre study	9
The role of precision medicine in head and neck cancer: A systematic study of ongoing clinical trials	9
P-105 Sternocleidomastoid Rotational Flap for Recurrent Parotid Malignancy	9
P-169 The Incidence of Thyroid Gland Invasion in Advanced Stage Laryngeal Cancers with Emphasis on Risk Factors and Its Impact on Survival	9
Editorial Board/Aims & Scope	9
P-99 SUCNR1 and SDHA Gene Expression in Tumoral Tissue Is Associated with Locoregional Disease-Free Survival	9
P-190 Personalized Immunotherapy with Cell-Encapsulation Technology for 2nd line R/M HNSCC: Safety and Early Efficacy Data from all HNSCC patients treated with MVX-ONCO-1 in two clinical trials	9
P-39 Locoregional failures after radical radiotherapy	9
Is Age ≥ 55 years an optimal cutoff point among patients with differentiated thyroid Microcarcinoma? a preliminary study	9
The usefulness of hybrid platform meetings for research ethics committees review meetings	9
P-111 Necrotizing Sialometaplasia: Differential diagnosis and treatment of a malignant masquerade	9
P-239 The Impact of the Introduction of a Triage Risk Calculator to the NHS Lothian (Scotland) Head and Neck Service	9
P-40 Radiotherapy with curative intent in head and neck cancer – Experience from a tertiary care center	9
Targeting cancer associated fibroblasts – A TGF-β based immunotherapy for head and neck squamous cell carcinoma	9
P-86 Tumor Recurrence on Pectoralis Major Myocutaneous Flap	9
Bacteriophages as novel tumor targeting therapy for oral squamous cell carcinoma (OSCC) cancer	9
Functional outcomes and tracheostomy dependence following salvage oropharyngeal surgery	9
Primary Ewing's sarcoma (ES)/peripheral primitive neuroectodermal tumor (pPNET) of the tongue in a child: A case report	9
P-193 Pediatric thyroid cancer: Risk factors for central lymph node metastasis in patients with cN0 papillary carcinoma	8
Role of salivary miRNAs as noninvasive biomarkers in head and neck squamous cell carcinomas and oral potentially malignant disorders – Reply	8
An unsolved dilemma in the reliability of virtual planning in mandibular reconstruction surgery: Short communication	8
P-195 A two-centre review of the management of cytologically suspicious thyroid nodules for Malignancy (Thy 4)	8
Prognostic impact of socioeconomic status compared to overall stage for HPV-negative head and neck squamous cell carcinoma	8
Sinonasal cancer encroaching the orbit: Ablation or preservation?	8
Personalized mRNA cancer vaccines with immune checkpoint inhibitors: A promising therapeutic approach in oral cancer patients	8
Adjuvant radiotherapy mitigates impact of perineural invasion on oncologic outcomes in early-stage oral cavity squamous cell carcinoma. A multi-institutional analysis of 557 patients	8
Dysregulation and implications of lncRNAs and miRNAs in oral tongue squamous cell carcinoma: In reply with emphasis on the role of ceRNAs	8
Evaluation of the matrix metalloproteinase 9 (MMP9) inhibitor Andecaliximab as an Anti-invasive therapeutic in Head and neck squamous cell carcinoma	8
Accelerated implementation of teleconsultation services for the monitoring of oral potentially malignant disorders as a result of the COVID-19 pandemic	8
P-22 Artifact reduction in head and neck CT images using polyetheretherketone (PEEK), polyetherketoneketone (PEKK), polyphenylsulfone (PPSU) and polyether (PE) polymer implants in mandible reconstruct	8
P-167 Comparison of Clinical and Pathological Staging in Patients with Head and Neck Cancer After Elective Neck Dissection	8
P-91 Correlation of outcomes with prognostic factors in early node negative and node positive Oral cavity Squamous Cell Carcinoma patients	8
Gingival rhabdomyosarcoma mimicking a non-neoplastic proliferative lesion: A diagnostic challenge	8
Nivolumab for recurrent or metastatic head and neck cancer patients with non-squamous cell carcinoma and/or a primary subsite excluded from CheckMate141, a retrospective study	8
Femoral artery-nourished anteromedial thigh flap: A new perspective in oral and maxillofacial defect reconstruction	8
Paratracheal lymph node dissection during total (pharyngo-)laryngectomy: A systematic review and meta-analysis	8
Locally advanced lymphoepithelial carcinoma of the larynx/hypopharynx: A case report	8
MYC-PDL1 axis reduces sensitivity to nivolumab in recurrent head and neck squamous cell carcinoma	8
Central oral medicine repository: A proposal to speed up the diagnostic process for oral potentially malignant disorders and oral carcinoma!	8
Combined Pik3ca-H1047R and loss-of-function Notch1 alleles decrease survival time in a 4-nitroquinoline N-oxide-driven head and neck squamous cell carcinoma model	8
O5.2 Nodal involvement determines the initial quantity of circulating free HPV16 DNA in patients with HPV-related oropharyngeal cancer	8
P-128 Long-term follow up of oral oncology patients after mandibular reconstruction	8
P-126 Benefits of reconstruction of oral cavity organs in oncological patients with reinnervated free flaps	8
P-79 Molecular Characterization of Locally Relapsed Head and Neck Cancer after Concomitant Chemoradiotherapy	8
Versatility of a single piece scapular tip and lateral border free flap for mandibular reconstruction: A virtual study on angle correspondence	8
Clinical outcomes of patients with pT4a and pT4b oral cavity squamous cell carcinoma who had undergone surgery: Results from a Taiwanese registry-based, nationwide cohort study	8
Phase I / II trial of metformin as a chemo-radiosensitizer in a head and neck cancer patient population	8
Objective evaluation of orbito-zygomatic reconstruction with scapular tip free flaps to restore facial projection and orbital volume	8
Oral leukoplakia in adolescents: Report of a rare case and review of the literature	8
A senescence-related lncRNA signature predicts prognosis and reflects immune landscape in HNSCC	8
Corrigendum to salivary microRNA- 375: A novel biomarker in the malignant transformation of oral potentially malignant disorders [Oral Oncol. 134 (2022) 106065]	8
Occult nodal metastasis in major salivary gland malignancy: An update from the National Cancer Database	8
Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen	7
Immunoinhibitory effects of hypoxia-driven reprogramming of EGR1hi and EGR3 positive B cells in the nasopharyngeal carcinoma microenvironment	7
Xerostomia prediction in patients with nasopharyngeal carcinoma during radiotherapy using segmental dose distribution in dosiomics and radiomics models	7
The Edmonton Symptom Assessment System: A narrative review of a standardized symptom assessment tool in head and neck oncology	7
The prognostic role of tumor associated macrophages in squamous cell carcinoma of the head and neck: A systematic review and meta-analysis	7
TIGIT/CD155 blockade enhances anti-PD-L1 therapy in head and neck squamous cell carcinoma by targeting myeloid-derived suppressor cells	7
Atezolizumab plus bevacizumab in advanced Merkel cell carcinoma: A prospective study	7
Successful treatment of oral potentially malignant lesions with ruxolitinib in STAT3 gain-of-function disease	7
Exosomal PD-L1 derived from head and neck squamous cell carcinoma promotes immune evasion by activating the positive feedback loop of activated regulatory T cell-M2 macrophage	7
Cell-free mitochondrial DNA as a novel non-invasive biomarker for oral cancer	7
Enhanced recovery after surgery (ERAS) in head and neck oncologic surgery: Impact on return to intended oncologic therapy (RIOT) and survival	7
Comments on the article titled “Factors associated with unknown primary status in head and neck squamous cell carcinoma”: Is the N status the overlooked elephant in the room?	7
Functional outcomes and complications of total glossectomy with laryngeal preservation and flap reconstruction: A systematic review and meta-analysis	7